Viewing Study NCT02268604


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-01-01 @ 10:45 AM
Study NCT ID: NCT02268604
Status: TERMINATED
Last Update Posted: 2014-10-20
First Post: 2014-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-10
Start Date Type: None
Primary Completion Date: 2010-10
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2014-08-21
First Submit QC Date: None
Study First Post Date: 2014-10-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-10-16
Last Update Post Date: 2014-10-20
Last Update Post Date Type: ESTIMATED